Search results
15 wrz 2022 · Complete thrombus resolution was achieved in 62.3% (n=99) at a median of 103 days (interquartile range, 32–392 days). 17 Recurrence of thrombus or an increase in LV thrombus area was observed in 14.5% (n=23), a finding associated with poor adherence, prothrombotic conditions, and increased mortality. 17.
- View EPUB
(r·=™Z¢ÔþÛôn =Yj > h~}¤ÄŽ@ ]|Ÿög š×/|ë@¾l÷ †u¢ÚsÅCÈù?\yÓ©b...
- Linda S. Williams
HRs for stroke recurrence ranged from 1.68 (95% CI,...
- PDF/Epub
PK u!3Yoa«, mimetypeapplication/epub+zipPK u!3Y...
- Trial
Background—The Randomized Evaluation of Long-term...
- Results From the GEIST
Left ventricular (LV) thrombus formation is a well‐known...
- Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome
Objective: Takotsubo syndrome (TTS) is characterized by...
- Stroke
National Center. 7272 Greenville Ave.Dallas, TX 75231....
- Peripartum Cardiomyopathy
Peripartum cardiomyopathy is a potentially life-threatening...
- View EPUB
We identified patients with LV thrombus on echocardiography (with and without contrast) at Brigham and Women’s Hospital between January 2008 and May 2015. Etiologies, treatment strategies, follow-up imaging, and 1-year outcomes were recorded after physician chart review.
17 kwi 2023 · However, in 115 patients with treated LV thrombus and who had documented resolution on repeat echocardiography, about 1 in 4 patients had recurrent LVT at a median follow‐up of 1.2 years, and about 1 in 5 patients with LVT recurrence experienced MACE.
Management of LV thrombus (LVT) is challenging and crucial to prevent the potential development of thromboembolic complications such as stroke. Anticoagulation with warfarin is recommended for the prevention of thromboembolic events, but novel oral anticoagulants (NOAC) have been used in clinical practice without supporting evidence.
25 lut 2021 · Patients with LVT have markedly high natriuretic peptides and experience a 20% 1 year risk for embolic events and/or death following diagnosis despite anticoagulant treatment. Most patients have favourable remodelling/recovery.
Abstract. Left ventricular thrombus (LVT) is a serious complication of acute myocardial infarction (MI) and also non-ischemic cardiomyopathies. We performed a narrative literature review, manual-search of reference lists of included articles and relevant reviews.
In the contemporary era, the most common precipitating factor for LV thrombus is HF; most patients are not on GDMT at the time of diagnosis. Warfarin remains the most commonly prescribed anticoagulant. Efficacy and safety of DOACs in treatment of LV thrombus requires a prospective clinical trial.
